Click for best price
Human Coagulation Factor ? Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor ?, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor ?. This report contains market size and forecasts of Human Coagulation Factor ? in global, including the following market information:
Global Human Coagulation Factor ? Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Human Coagulation Factor ? market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Recombinant Factor VIII Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Coagulation Factor ? include Bayer, CSL Behring, Baxter, Grifols, Octapharma, Pfizer, Taibang Bio, Shanghai Laishi and Hualan Bio, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Coagulation Factor ? companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Coagulation Factor ? Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Human Coagulation Factor ? Market Segment Percentages, by Type, 2022 (%)
Recombinant Factor VIII
Human Factor VIII
Global Human Coagulation Factor ? Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Human Coagulation Factor ? Market Segment Percentages, by Application, 2022 (%)
Hemophilia A
Relvent Bleeding Diseases
Global Human Coagulation Factor ? Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Human Coagulation Factor ? Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Coagulation Factor ? revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Human Coagulation Factor ? revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
CSL Behring
Baxter
Grifols
Octapharma
Pfizer
Taibang Bio
Shanghai Laishi
Hualan Bio
Guangdong Shuanglin
GreenCross
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Coagulation Factor ?, market overview.
Chapter 2: Global Human Coagulation Factor ? market size in revenue.
Chapter 3: Detailed analysis of Human Coagulation Factor ? company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Coagulation Factor ? in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Human Coagulation Factor ? Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Coagulation Factor ? Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Coagulation Factor ? Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Coagulation Factor ? Overall Market Size
2.1 Global Human Coagulation Factor ? Market Size: 2022 VS 2029
2.2 Global Human Coagulation Factor ? Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Coagulation Factor ? Players in Global Market
3.2 Top Global Human Coagulation Factor ? Companies Ranked by Revenue
3.3 Global Human Coagulation Factor ? Revenue by Companies
3.4 Top 3 and Top 5 Human Coagulation Factor ? Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Coagulation Factor ? Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Coagulation Factor ? Players in Global Market
3.6.1 List of Global Tier 1 Human Coagulation Factor ? Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Coagulation Factor ? Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Coagulation Factor ? Market Size Markets, 2022 & 2029
4.1.2 Recombinant Factor VIII
4.1.3 Human Factor VIII
4.2 By Type - Global Human Coagulation Factor ? Revenue & Forecasts
4.2.1 By Type - Global Human Coagulation Factor ? Revenue, 2018-2023
4.2.2 By Type - Global Human Coagulation Factor ? Revenue, 2024-2029
4.2.3 By Type - Global Human Coagulation Factor ? Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Coagulation Factor ? Market Size, 2022 & 2029
5.1.2 Hemophilia A
5.1.3 Relvent Bleeding Diseases
5.2 By Application - Global Human Coagulation Factor ? Revenue & Forecasts
5.2.1 By Application - Global Human Coagulation Factor ? Revenue, 2018-2023
5.2.2 By Application - Global Human Coagulation Factor ? Revenue, 2024-2029
5.2.3 By Application - Global Human Coagulation Factor ? Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Human Coagulation Factor ? Market Size, 2022 & 2029
6.2 By Region - Global Human Coagulation Factor ? Revenue & Forecasts
6.2.1 By Region - Global Human Coagulation Factor ? Revenue, 2018-2023
6.2.2 By Region - Global Human Coagulation Factor ? Revenue, 2024-2029
6.2.3 By Region - Global Human Coagulation Factor ? Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Human Coagulation Factor ? Revenue, 2018-2029
6.3.2 US Human Coagulation Factor ? Market Size, 2018-2029
6.3.3 Canada Human Coagulation Factor ? Market Size, 2018-2029
6.3.4 Mexico Human Coagulation Factor ? Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Human Coagulation Factor ? Revenue, 2018-2029
6.4.2 Germany Human Coagulation Factor ? Market Size, 2018-2029
6.4.3 France Human Coagulation Factor ? Market Size, 2018-2029
6.4.4 U.K. Human Coagulation Factor ? Market Size, 2018-2029
6.4.5 Italy Human Coagulation Factor ? Market Size, 2018-2029
6.4.6 Russia Human Coagulation Factor ? Market Size, 2018-2029
6.4.7 Nordic Countries Human Coagulation Factor ? Market Size, 2018-2029
6.4.8 Benelux Human Coagulation Factor ? Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Human Coagulation Factor ? Revenue, 2018-2029
6.5.2 China Human Coagulation Factor ? Market Size, 2018-2029
6.5.3 Japan Human Coagulation Factor ? Market Size, 2018-2029
6.5.4 South Korea Human Coagulation Factor ? Market Size, 2018-2029
6.5.5 Southeast Asia Human Coagulation Factor ? Market Size, 2018-2029
6.5.6 India Human Coagulation Factor ? Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Human Coagulation Factor ? Revenue, 2018-2029
6.6.2 Brazil Human Coagulation Factor ? Market Size, 2018-2029
6.6.3 Argentina Human Coagulation Factor ? Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Coagulation Factor ? Revenue, 2018-2029
6.7.2 Turkey Human Coagulation Factor ? Market Size, 2018-2029
6.7.3 Israel Human Coagulation Factor ? Market Size, 2018-2029
6.7.4 Saudi Arabia Human Coagulation Factor ? Market Size, 2018-2029
6.7.5 UAE Human Coagulation Factor ? Market Size, 2018-2029
7 Human Coagulation Factor ? Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Human Coagulation Factor ? Major Product Offerings
7.1.4 Bayer Human Coagulation Factor ? Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 CSL Behring
7.2.1 CSL Behring Company Summary
7.2.2 CSL Behring Business Overview
7.2.3 CSL Behring Human Coagulation Factor ? Major Product Offerings
7.2.4 CSL Behring Human Coagulation Factor ? Revenue in Global Market (2018-2023)
7.2.5 CSL Behring Key News & Latest Developments
7.3 Baxter
7.3.1 Baxter Company Summary
7.3.2 Baxter Business Overview
7.3.3 Baxter Human Coagulation Factor ? Major Product Offerings
7.3.4 Baxter Human Coagulation Factor ? Revenue in Global Market (2018-2023)
7.3.5 Baxter Key News & Latest Developments
7.4 Grifols
7.4.1 Grifols Company Summary
7.4.2 Grifols Business Overview
7.4.3 Grifols Human Coagulation Factor ? Major Product Offerings
7.4.4 Grifols Human Coagulation Factor ? Revenue in Global Market (2018-2023)
7.4.5 Grifols Key News & Latest Developments
7.5 Octapharma
7.5.1 Octapharma Company Summary
7.5.2 Octapharma Business Overview
7.5.3 Octapharma Human Coagulation Factor ? Major Product Offerings
7.5.4 Octapharma Human Coagulation Factor ? Revenue in Global Market (2018-2023)
7.5.5 Octapharma Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Human Coagulation Factor ? Major Product Offerings
7.6.4 Pfizer Human Coagulation Factor ? Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Taibang Bio
7.7.1 Taibang Bio Company Summary
7.7.2 Taibang Bio Business Overview
7.7.3 Taibang Bio Human Coagulation Factor ? Major Product Offerings
7.7.4 Taibang Bio Human Coagulation Factor ? Revenue in Global Market (2018-2023)
7.7.5 Taibang Bio Key News & Latest Developments
7.8 Shanghai Laishi
7.8.1 Shanghai Laishi Company Summary
7.8.2 Shanghai Laishi Business Overview
7.8.3 Shanghai Laishi Human Coagulation Factor ? Major Product Offerings
7.8.4 Shanghai Laishi Human Coagulation Factor ? Revenue in Global Market (2018-2023)
7.8.5 Shanghai Laishi Key News & Latest Developments
7.9 Hualan Bio
7.9.1 Hualan Bio Company Summary
7.9.2 Hualan Bio Business Overview
7.9.3 Hualan Bio Human Coagulation Factor ? Major Product Offerings
7.9.4 Hualan Bio Human Coagulation Factor ? Revenue in Global Market (2018-2023)
7.9.5 Hualan Bio Key News & Latest Developments
7.10 Guangdong Shuanglin
7.10.1 Guangdong Shuanglin Company Summary
7.10.2 Guangdong Shuanglin Business Overview
7.10.3 Guangdong Shuanglin Human Coagulation Factor ? Major Product Offerings
7.10.4 Guangdong Shuanglin Human Coagulation Factor ? Revenue in Global Market (2018-2023)
7.10.5 Guangdong Shuanglin Key News & Latest Developments
7.11 GreenCross
7.11.1 GreenCross Company Summary
7.11.2 GreenCross Business Overview
7.11.3 GreenCross Human Coagulation Factor ? Major Product Offerings
7.11.4 GreenCross Human Coagulation Factor ? Revenue in Global Market (2018-2023)
7.11.5 GreenCross Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Human Coagulation Factor ? Market Opportunities & Trends in Global Market
Table 2. Human Coagulation Factor ? Market Drivers in Global Market
Table 3. Human Coagulation Factor ? Market Restraints in Global Market
Table 4. Key Players of Human Coagulation Factor ? in Global Market
Table 5. Top Human Coagulation Factor ? Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Human Coagulation Factor ? Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Human Coagulation Factor ? Revenue Share by Companies, 2018-2023
Table 8. Global Companies Human Coagulation Factor ? Product Type
Table 9. List of Global Tier 1 Human Coagulation Factor ? Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Coagulation Factor ? Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Coagulation Factor ? Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Human Coagulation Factor ? Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Human Coagulation Factor ? Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Human Coagulation Factor ? Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Human Coagulation Factor ? Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Human Coagulation Factor ? Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Human Coagulation Factor ? Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Human Coagulation Factor ? Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Human Coagulation Factor ? Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Human Coagulation Factor ? Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Human Coagulation Factor ? Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Human Coagulation Factor ? Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Human Coagulation Factor ? Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Human Coagulation Factor ? Revenue, (US$, Mn), 2024-2029
Table 30. Bayer Company Summary
Table 31. Bayer Human Coagulation Factor ? Product Offerings
Table 32. Bayer Human Coagulation Factor ? Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. CSL Behring Company Summary
Table 35. CSL Behring Human Coagulation Factor ? Product Offerings
Table 36. CSL Behring Human Coagulation Factor ? Revenue (US$, Mn) & (2018-2023)
Table 37. CSL Behring Key News & Latest Developments
Table 38. Baxter Company Summary
Table 39. Baxter Human Coagulation Factor ? Product Offerings
Table 40. Baxter Human Coagulation Factor ? Revenue (US$, Mn) & (2018-2023)
Table 41. Baxter Key News & Latest Developments
Table 42. Grifols Company Summary
Table 43. Grifols Human Coagulation Factor ? Product Offerings
Table 44. Grifols Human Coagulation Factor ? Revenue (US$, Mn) & (2018-2023)
Table 45. Grifols Key News & Latest Developments
Table 46. Octapharma Company Summary
Table 47. Octapharma Human Coagulation Factor ? Product Offerings
Table 48. Octapharma Human Coagulation Factor ? Revenue (US$, Mn) & (2018-2023)
Table 49. Octapharma Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Human Coagulation Factor ? Product Offerings
Table 52. Pfizer Human Coagulation Factor ? Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Taibang Bio Company Summary
Table 55. Taibang Bio Human Coagulation Factor ? Product Offerings
Table 56. Taibang Bio Human Coagulation Factor ? Revenue (US$, Mn) & (2018-2023)
Table 57. Taibang Bio Key News & Latest Developments
Table 58. Shanghai Laishi Company Summary
Table 59. Shanghai Laishi Human Coagulation Factor ? Product Offerings
Table 60. Shanghai Laishi Human Coagulation Factor ? Revenue (US$, Mn) & (2018-2023)
Table 61. Shanghai Laishi Key News & Latest Developments
Table 62. Hualan Bio Company Summary
Table 63. Hualan Bio Human Coagulation Factor ? Product Offerings
Table 64. Hualan Bio Human Coagulation Factor ? Revenue (US$, Mn) & (2018-2023)
Table 65. Hualan Bio Key News & Latest Developments
Table 66. Guangdong Shuanglin Company Summary
Table 67. Guangdong Shuanglin Human Coagulation Factor ? Product Offerings
Table 68. Guangdong Shuanglin Human Coagulation Factor ? Revenue (US$, Mn) & (2018-2023)
Table 69. Guangdong Shuanglin Key News & Latest Developments
Table 70. GreenCross Company Summary
Table 71. GreenCross Human Coagulation Factor ? Product Offerings
Table 72. GreenCross Human Coagulation Factor ? Revenue (US$, Mn) & (2018-2023)
Table 73. GreenCross Key News & Latest Developments
List of Figures
Figure 1. Human Coagulation Factor ? Segment by Type in 2022
Figure 2. Human Coagulation Factor ? Segment by Application in 2022
Figure 3. Global Human Coagulation Factor ? Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Coagulation Factor ? Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Coagulation Factor ? Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Coagulation Factor ? Revenue in 2022
Figure 8. By Type - Global Human Coagulation Factor ? Revenue Market Share, 2018-2029
Figure 9. By Application - Global Human Coagulation Factor ? Revenue Market Share, 2018-2029
Figure 10. By Type - Global Human Coagulation Factor ? Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Human Coagulation Factor ? Revenue Market Share, 2018-2029
Figure 12. By Application - Global Human Coagulation Factor ? Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Human Coagulation Factor ? Revenue Market Share, 2018-2029
Figure 14. By Region - Global Human Coagulation Factor ? Revenue Market Share, 2018-2029
Figure 15. By Country - North America Human Coagulation Factor ? Revenue Market Share, 2018-2029
Figure 16. US Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Human Coagulation Factor ? Revenue Market Share, 2018-2029
Figure 20. Germany Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 21. France Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Human Coagulation Factor ? Revenue Market Share, 2018-2029
Figure 28. China Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 32. India Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Human Coagulation Factor ? Revenue Market Share, 2018-2029
Figure 34. Brazil Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Human Coagulation Factor ? Revenue Market Share, 2018-2029
Figure 37. Turkey Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Human Coagulation Factor ? Revenue, (US$, Mn), 2018-2029
Figure 41. Bayer Human Coagulation Factor ? Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. CSL Behring Human Coagulation Factor ? Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Baxter Human Coagulation Factor ? Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Grifols Human Coagulation Factor ? Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Octapharma Human Coagulation Factor ? Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Human Coagulation Factor ? Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Taibang Bio Human Coagulation Factor ? Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Shanghai Laishi Human Coagulation Factor ? Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Hualan Bio Human Coagulation Factor ? Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Guangdong Shuanglin Human Coagulation Factor ? Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. GreenCross Human Coagulation Factor ? Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
